DNA製造の市場規模、シェア、動向分析レポート：タイプ別、グレード別、用途別、最終用途別、地域別、セグメント予測、2025～2030年

DNA製造市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のDNA製造の市場規模は2030年までに149億6,000万米ドルに達し、2025～2030年までのCAGRは18.10％で成長すると予測されています。

DNA製造市場は、合成生物学アプリケーション、個別化治療薬、高度なワクチン開発に対する需要の高まりによって急速に発展しています。バイオテクノロジー企業、学術機関、受託開発製造組織 (CDMO) 間の連携の増加により、イノベーションが加速し、市場へのアクセスが拡大しています。遺伝子合成、酵素DNA生産、自動化における技術の進歩は、DNA製造プロセスの拡張性、スピード、精度を向上させています。

この市場は、遺伝子治療、mRNAワクチン、診断アッセイ開発、細胞工学など、さまざまな用途で重要な役割を担っているため、勢いを増しています。高品質のプラスミドDNAとGMPグレードの材料に対するニーズが高まるにつれ、新興企業やレガシープロバイダーは、世界の需要に応えるべくその能力を拡大しています。

酵素合成、無細胞システム、連続製造における革新は、従来のワークフローを再構築し、より迅速なターンアラウンドタイムを可能にしています。これらの進歩は、腫瘍学、感染症、再生医療におけるDNAベースのツールの幅広い採用を支えています。

この分野が成熟するにつれて、DNA製造市場は次世代のバイオ治療薬、診断薬、精密医療ソリューションを推進する上で中心的な位置を占めるようになります。

DNA製造市場レポートのハイライト

• タイプ別では、合成DNAが2024年のDNA製造市場を独占しました。この優位性は、その柔軟性、拡張性、合成生物学、ゲノム編集、診断、次世代治療における役割の拡大に起因します。酵素合成と自動化の進歩により、製造時間とコストが大幅に削減され、カスタムDNA配列の迅速かつ高忠実度の生成が可能になりました。製薬、農業、産業バイオテクノロジーの各分野で精密工学的DNAの需要が高まるにつれ、合成DNAは技術革新と採用において従来の方法を凌駕し続けています。
• グレード別では、研究開発グレードのDNAが2024年のDNA製造市場を独占しました。この優位性は主に、学術機関、バイオテクノロジー新興企業、初期段階の医薬品開発において研究開発グレードのDNAが広く使用されていることによるものです。遺伝子編集、合成生物学、ワクチン研究の革新が加速し、実験および前臨床試験用の費用対効果の高い高品質DNAの需要が高まり続けています。研究開発グレードのDNAは柔軟性があり、納期が早いため、反復試験、概念実証試験、技術開発において不可欠なリソースとなっています。
• 用途別では、細胞・遺伝子治療が2024年のDNA製造市場を席巻し、43.90%の市場シェアを占めました。このリーダーシップは、がん、希少遺伝性疾患、再生医療をターゲットとした遺伝子ベースの治療プラットフォームの急速な進歩によってもたらされました。細胞治療や遺伝子治療のパイプラインでベクターやテンプレート、原料として使用される高純度プラスミドや合成DNAに対する高い需要が、生産要件を大幅に高めています。
• 最終用途別では、製薬・バイオテクノロジー企業が2024年のDNA製造市場を独占し、48.68%の市場シェアを占めました。遺伝子治療、ワクチン製造、生物製剤開発におけるDNAベースのインプットに対する需要の急増が、この優位性を後押ししています。これらの企業が臨床パイプラインを前進させ、新規治療薬を市場に投入するにつれて、高品質でスケーラブルなDNA製造への依存は高まり続けています。精密医療、腫瘍学、希少疾患治療においてDNA技術の採用が進んでいることも、同分野のリーダーとしての地位をさらに強固なものにしています。
• 2025年5月、核酸ベースの治療薬に特化した開発・製造受託機関（CDMO）であるVGXI, Inc.は、テキサス州コンローの施設で米国食品医薬品局（FDA）の査察が無事終了したことを発表しました。このマイルストーンにより、VGXIのクライアントは、遺伝子治療やmRNAワクチンの重要な構成要素であるプラスミドDNAを含む臨床試験の生物製剤承認申請（BLA）を提出することができます。VGXIの業績は、スケーラブルで高純度な生産能力を提供するプラスミドDNA製造におけるリーダーシップを強調するものです。同社は、生命を変える医学研究とイノベーションを世界中で推進する信頼できるパートナーです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• DNA製造市場の分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 DNA製造市場：タイプ別のビジネス分析

• タイプ別セグメントダッシュボード
• 世界のDNA製造市場：タイプ別の変動分析
• 世界のDNA製造市場規模と動向分析（タイプ別、2018～2030年）
• プラスミドDNA
• 合成DNA

第5章 DNA製造市場：グレード別のビジネス分析

• グレード別セグメントダッシュボード
• 世界のDNA製造市場：グレード別の変動分析
• 世界のDNA製造市場規模と動向分析（グレード別、2018～2030年）
• GMPグレード
• 研究開発グレード

第6章 DNA製造市場：用途別のビジネス分析

• 用途別セグメントダッシュボード
• 世界のDNA製造市場：用途別の変動分析
• 世界のDNA製造市場規模と動向分析（用途別、2018～2030年）
• 細胞・遺伝子治療
• ワクチン
• オリゴヌクレオチドベースの医薬品
• その他

第7章 DNA製造市場：最終用途別のビジネス分析

• 最終用途別セグメントダッシュボード
• 世界のDNA製造市場：最終用途別の変動分析
• 世界のDNA製造市場規模と動向分析（最終用途別、2018～2030年）
• 製薬・バイオテクノロジー企業
• 学術研究機関
• 契約研究機関

第8章 DNA製造市場：地域別の推定・動向分析

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Charles River Laboratories
  • VGXI, Inc.
  • Danaher（Aldevron）
  • Thermo Fisher Scientific
  • Lonza
  • GenScript
  • Catalent
  • Wuxi AppTec
  • Kaneka Corp.
  • Eurofins Genomics

List of Tables

• Table 1 North America DNA manufacturing market estimates & forecasts
• Table 2 North America DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 3 North America DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 4 North America DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 5 North America DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 6 U.S DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 7 U.S DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 8 U.S DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 9 U.S DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 10 Canada DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 11 Canada DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 12 Canada DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 13 Canada DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 14 Mexico DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 15 Mexico DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 16 Mexico DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 17 Mexico DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 18 Europe DNA manufacturing market estimates & forecasts
• Table 19 Europe DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 20 Europe DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 21 Europe DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 22 Europe DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 23 UK DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 24 UK DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 25 UK DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 26 UK DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 27 Germany DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 28 Germany DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 29 Germany DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 30 Germany DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 31 France DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 32 France DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 33 France DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 34 France DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 36 Spain DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 37 Spain DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 38 Spain DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 39 Italy DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 40 Italy DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 41 Italy DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 42 Italy DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 43 Denmark DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 44 Denmark DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 45 Denmark DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 46 Denmark DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 47 Sweden DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 48 Sweden DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 49 Sweden DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 50 Sweden DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 51 Norway DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 52 Norway DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 53 Norway DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 54 Norway DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific DNA manufacturing market estimates & forecasts
• Table 56 Asia Pacific DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 60 China DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 61 China DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 62 China DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 63 China DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 64 Japan DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 65 Japan DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 66 Japan DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 67 Japan DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 68 India DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 69 India DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 70 India DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 71 India DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 72 South Korea DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 73 South Korea DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 74 South Korea DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 75 South Korea DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 76 Australia DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 77 Australia DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 78 Australia DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 79 Australia DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 80 Thailand DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 81 Thailand DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 82 Thailand DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 83 Thailand DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 84 Latin America DNA manufacturing market estimates & forecasts
• Table 85 Latin America DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 86 Latin America DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 87 Latin America DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 88 Latin America DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 89 Brazil DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 90 Brazil DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 91 Brazil DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 92 Brazil DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 93 Argentina DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 94 Argentina DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 95 Argentina DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 96 Argentina DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 97 MEA DNA manufacturing market estimates & forecasts
• Table 98 MEA DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 99 MEA DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 100 MEA DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 101 MEA DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 102 South Africa DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 103 South Africa DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 104 South Africa DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 105 South Africa DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 110 UAE DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 111 UAE DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 112 UAE DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 113 UAE DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 114 Kuwait DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 115 Kuwait DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
• Table 116 Kuwait DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
• Table 117 Kuwait DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market snapshot
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market trends & outlook
• Fig. 7 Market segmentation & scope
• Fig. 8 Market driver relevance analysis (Current & future impact)
• Fig. 9 Market restraint relevance analysis (Current & future impact)
• Fig. 10 PESTLE Analysis
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Strategy framework
• Fig. 13 DNA manufacturing market: Type outlook key takeaways
• Fig. 14 DNA manufacturing market: Type movement analysis
• Fig. 15 Plasmid DNA market, 2018 - 2030 (USD Million)
• Fig. 16 Synthetic DNA market, 2018 - 2030 (USD Million)
• Fig. 17 Gene synthesis market, 2018 - 2030 (USD Million)
• Fig. 18 Oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 19 DNA Manufacturing market: Grade outlook key takeaways
• Fig. 20 DNA Manufacturing market: Grade movement analysis
• Fig. 21 GMP grade market, 2018 - 2030 (USD Million)
• Fig. 22 R&D grade market, 2018 - 2030 (USD Million)
• Fig. 23 DNA manufacturing market: Application outlook key takeaways
• Fig. 24 DNA manufacturing market: Application movement analysis
• Fig. 25 Cell & gene therapy market, 2018 - 2030 (USD Million)
• Fig. 26 Vaccines market, 2018 - 2030 (USD Million)
• Fig. 27 Oligonucleotide-based drugs market, 2018 - 2030 (USD Million)
• Fig. 28 Others market, 2018 - 2030 (USD Million)
• Fig. 29 DNA Manufacturing market: End Use outlook key takeaways
• Fig. 30 DNA Manufacturing market: End Use movement analysis
• Fig. 31 Pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 32 Contract research organizations market, 2018 - 2030 (USD Million)
• Fig. 33 Academic & research institutes market, 2018 - 2030 (USD Million)
• Fig. 34 DNA manufacturing market, by region, 2018 - 2030 (USD Million)
• Fig. 35 North America DNA manufacturing market, by country, 2018 - 2030 (USD Million)
• Fig. 36 U.S. DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 37 Canada DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 38 Mexico DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 39 Europe DNA manufacturing market, by country, 2018 - 2030 (USD Million)
• Fig. 40 UK DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 41 Germany DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 42 France DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 43 Italy DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 44 Spain DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 45 Denmark DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 46 Sweden DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 47 Norway DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 48 Asia Pacific DNA manufacturing market, by country, 2018 - 2030 (USD Million)
• Fig. 49 Japan DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 50 China DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 51 India DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 52 Australia DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 53 South Korea DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 54 Thailand DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 55 Latin America DNA manufacturing market, by country, 2018 - 2030 (USD Million)
• Fig. 56 Brazil DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 57 Argentina DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 58 Middle East & Africa DNA manufacturing market, by country, 2018 - 2030 (USD Million)
• Fig. 59 South Africa DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 60 Saudi Arabia DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 61 UAE DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 62 Kuwait DNA manufacturing market, 2018 - 2030 (USD Million)
• Fig. 63 Key companies profiled

DNA Manufacturing Market Growth & Trends:

The global DNA manufacturing market size is projected to reach USD 14.96 billion by 2030, growing at a CAGR of 18.10% from 2025 to 2030, according to a new report by Grand View Research, Inc. The DNA manufacturing market is rapidly evolving, driven by rising demand for synthetic biology applications, personalized therapeutics, and advanced vaccine development. Increasing collaboration between biotech firms, academic institutions, and contract development and manufacturing organizations (CDMOs) is accelerating innovation and expanding market access. Technological advancements in gene synthesis, enzymatic DNA production, and automation enhance DNA manufacturing processes' scalability, speed, and precision.

This market is gaining momentum due to its critical role in various applications, including gene therapy, mRNA vaccines, diagnostic assay development, and cell engineering. As the need for high-quality plasmid DNA and GMP-grade materials grows, startups and legacy providers are expanding their capabilities to meet global demand.

Innovations in enzymatic synthesis, cell-free systems, and continuous manufacturing are reshaping traditional workflows and enabling faster turnaround times. These advancements support the broader adoption of DNA-based tools in oncology, infectious diseases, and regenerative medicine.

As the field matures, the DNA manufacturing market is positioned to be central in advancing the next generation of biotherapeutics, diagnostics, and precision health solutions.

DNA Manufacturing Market Report Highlights:

• Based on type, synthetic DNA dominated the DNA manufacturing market in 2024. This dominance is attributed to its flexibility, scalability, and expanding role in synthetic biology, genome editing, diagnostics, and next-generation therapeutics. Advances in enzymatic synthesis and automation have significantly reduced production time and costs, enabling the rapid, high-fidelity generation of custom DNA sequences. As demand grows for precision-engineered DNA across pharmaceutical, agricultural, and industrial biotech sectors, synthetic DNA continues to outpace traditional methods in innovation and adoption.
• Based on grade, R&D-grade DNA dominated the DNA manufacturing market in 2024. This dominance is primarily due to the widespread use of research-grade DNA in academic institutions, biotech startups, and early-stage drug development. Innovation in gene editing, synthetic biology, and vaccine research accelerates, and demand for cost-effective, high-quality DNA for experimental and preclinical studies continues to rise. The flexibility and faster turnaround of R&D-grade DNA make it an essential resource in iterative testing, proof-of-concept studies, and technology development.
• Based on application, cell and gene therapy dominated the DNA manufacturing market in 2024, accounting for 43.90% market share. This leadership is driven by the rapid advancement of gene-based therapeutic platforms targeting cancer, rare genetic disorders, and regenerative medicine. High demand for high-purity plasmid and synthetic DNA for use as vectors, templates, or raw material in cell and gene therapy pipelines has significantly increased production requirements.
• Based on end use, pharmaceutical and biotechnology companies dominated the DNA manufacturing market in 2024, accounting for 48.68% market share. The surge in demand for DNA-based inputs across gene therapy, vaccine production, and biologics development drives this dominance. As these companies advance clinical pipelines and bring novel therapeutics to market, their reliance on high-quality, scalable DNA manufacturing continues to grow. The increasing adoption of DNA technologies in precision medicine, oncology, and rare disease treatment further reinforces this segment's leadership.
• In May 2025, VGXI, Inc., a contract development and manufacturing organization (CDMO) specializing in nucleic acid-based therapeutics, announced the successful completion of a U.S. Food and Drug Administration (FDA) inspection at its Conroe, Texas facility. This milestone enables VGXI's client to submit a Biologics License Application (BLA) for clinical trials involving plasmid DNA, a critical component in gene therapies and mRNA vaccines. VGXI's achievement underscores its leadership in plasmid DNA manufacturing, offering scalable and high-purity production capabilities. The company has been a trusted partner in advancing life-changing medical research and innovation worldwide

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Type Segment
  • 1.2.2. Grade Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. DNA Manufacturing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNA Manufacturing Market: Type Business Analysis

• 4.1. Type Segment Dashboard
• 4.2. Global DNA Manufacturing Market Type Movement Analysis
• 4.3. Global DNA Manufacturing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Plasmid DNA
  • 4.4.1. Global Plasmid DNA based Market, 2018 - 2030 (USD Million)
• 4.5. Synthetic DNA
  • 4.5.1. Global Synthetic DNA Market, 2018 - 2030 (USD Million)
    • 4.5.1.1. Gene Synthesis
      • 4.5.1.1.1. Global Gene Synthesis Market, 2018 - 2030 (USD Million)
    • 4.5.1.2. Oligonucleotide Synthesis
      • 4.5.1.2.1. Global Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)

Chapter 5. DNA Manufacturing Market: Grade Business Analysis

• 5.1. Grade Segment Dashboard
• 5.2. Global DNA Manufacturing Market Grade Movement Analysis
• 5.3. Global DNA Manufacturing Market Size & Trend Analysis, by Grade, 2018 to 2030 (USD Million)
• 5.4. GMP Grade
  • 5.4.1. Global GMP Grade Market, 2018 - 2030 (USD Million)
• 5.5. R&D Grade
  • 5.5.1. Global R&D Grade Market, 2018 - 2030 (USD Million)

Chapter 6. DNA Manufacturing Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global DNA Manufacturing Market Application Movement Analysis
• 6.3. Global DNA Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Cell & Gene Therapy
  • 6.4.1. Global Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
• 6.5. Vaccines
  • 6.5.1. Global Vaccines Market, 2018 - 2030 (USD Million)
• 6.6. Oligonucleotide-based Drugs
  • 6.6.1. Global Oligonucleotide-based Drugs Market, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 7. DNA Manufacturing Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global DNA Manufacturing Market End Use Movement Analysis
• 7.3. Global DNA Manufacturing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical and Biotechnology Companies
  • 7.4.1. Global Pharmaceutical and Biotechnology Companies Devices Market, 2018 - 2030 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• 7.6. Contract Research Organizations
  • 7.6.1. Global Contract Research Organizations Market, 2018 - 2030 (USD Million)

Chapter 8. Regional DNA Manufacturing Market: Region Estimates & Trend Analysis

• 8.1. North America
  • 8.1.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.1.2. U.S.
    • 8.1.2.1. Key country dynamics
    • 8.1.2.2. Competitive scenario
    • 8.1.2.3. Regulatory Framework
    • 8.1.2.4. Target Disease Prevalence
    • 8.1.2.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.1.3. Canada
    • 8.1.3.1. Key country dynamics
    • 8.1.3.2. Competitive scenario
    • 8.1.3.3. Regulatory Framework
    • 8.1.3.4. Target Disease Prevalence
    • 8.1.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.1.4. Mexico
    • 8.1.4.1. Key country dynamics
    • 8.1.4.2. Competitive scenario
    • 8.1.4.3. Regulatory Framework
    • 8.1.4.4. Target Disease Prevalence
    • 8.1.4.5. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
• 8.2. Europe
  • 8.2.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.2. UK
    • 8.2.2.1. Key country dynamics
    • 8.2.2.2. Competitive scenario
    • 8.2.2.3. Regulatory Framework
    • 8.2.2.4. Target Disease Prevalence
    • 8.2.2.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.3. Germany
    • 8.2.3.1. Key country dynamics
    • 8.2.3.2. Competitive scenario
    • 8.2.3.3. Regulatory Framework
    • 8.2.3.4. Target Disease Prevalence
    • 8.2.3.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.4. France
    • 8.2.4.1. Key country dynamics
    • 8.2.4.2. Competitive scenario
    • 8.2.4.3. Regulatory Framework
    • 8.2.4.4. Target Disease Prevalence
    • 8.2.4.5. France market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.5. Italy
    • 8.2.5.1. Key country dynamics
    • 8.2.5.2. Competitive scenario
    • 8.2.5.3. Regulatory Framework
    • 8.2.5.4. Target Disease Prevalence
    • 8.2.5.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.6. Spain
    • 8.2.6.1. Key country dynamics
    • 8.2.6.2. Competitive scenario
    • 8.2.6.3. Regulatory Framework
    • 8.2.6.4. Target Disease Prevalence
    • 8.2.6.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.7. Norway
    • 8.2.7.1. Key country dynamics
    • 8.2.7.2. Competitive scenario
    • 8.2.7.3. Regulatory Framework
    • 8.2.7.4. Target Disease Prevalence
    • 8.2.7.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.8. Sweden
    • 8.2.8.1. Key country dynamics
    • 8.2.8.2. Competitive scenario
    • 8.2.8.3. Regulatory Framework
    • 8.2.8.4. Target Disease Prevalence
    • 8.2.8.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.9. Denmark
    • 8.2.9.1. Key country dynamics
    • 8.2.9.2. Competitive scenario
    • 8.2.9.3. Regulatory Framework
    • 8.2.9.4. Target Disease Prevalence
    • 8.2.9.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
• 8.3. Asia Pacific
  • 8.3.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.2. Japan
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. Target Disease Prevalence
    • 8.3.2.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.3. China
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Target Disease Prevalence
    • 8.3.3.5. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.4. India
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Target Disease Prevalence
    • 8.3.4.5. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.5. Thailand
    • 8.3.5.1. Key country dynamics
    • 8.3.5.2. Competitive scenario
    • 8.3.5.3. Regulatory Framework
    • 8.3.5.4. Target Disease Prevalence
    • 8.3.5.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.6. South Korea
    • 8.3.6.1. Key country dynamics
    • 8.3.6.2. Competitive scenario
    • 8.3.6.3. Regulatory Framework
    • 8.3.6.4. Target Disease Prevalence
    • 8.3.6.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.7. Australia
    • 8.3.7.1. Key country dynamics
    • 8.3.7.2. Competitive scenario
    • 8.3.7.3. Regulatory Framework
    • 8.3.7.4. Target Disease Prevalence
    • 8.3.7.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
• 8.4. Latin America
  • 8.4.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.4.2. Brazil
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Target Disease Prevalence
    • 8.4.2.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.4.3. Argentina
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Target Disease Prevalence
    • 8.4.3.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
• 8.5. Middle East & Africa
  • 8.5.1. Middle East & Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.2. South Africa
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Target Disease Prevalence
    • 8.5.2.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.3. Saudi Arabia
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Target Disease Prevalence
    • 8.5.3.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.4. UAE
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Target Disease Prevalence
    • 8.5.4.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.5. Kuwait
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Target Disease Prevalence
    • 8.5.5.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Charles River Laboratories
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Service Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. VGXI, Inc.
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Service Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Danaher (Aldevron)
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Service Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Thermo Fisher Scientific
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Service Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Lonza
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Service Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. GenScript
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Service Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Catalent
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Service Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Wuxi AppTec
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Service Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Kaneka Corp.
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Service Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Eurofins Genomics
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Service Benchmarking
    • 9.4.10.4. Strategic Initiatives